Concord Medical Services Limited

CCM | NYSE

Price Alert Chart Builder DCF Calculator

$3.71

-$0.03 (-0.80%)

At close: Sep 22, 2026, 3:59 PM ET

$3.88

+$0.17 (+4.58%)

After-hours: Sep 22, 2026, 7:26 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $544.6K

Enterprise Value $3.34B

Beta -0.94

Average Volume 68.94K

Shares Outstanding (Diluted) 144.72K

Shares Change YoY -0.61%

Institutional Ownership N/A

Exchange NYSE

ISIN US2062772049

Price Performance

Price Change 1M -29.9%

Price Change 3M -18.6%

Price Change 6M 1.6%

Price Change YTD -13.1%

Price Change 1Y -38.6%

Price Change 3Y -71.0%

Price Change 5Y -87.4%

1M CAGR (ann.) -17.4%

1Y CAGR (ann.) -27.2%

5Y CAGR (ann.) -33.9%

All-Time CAGR -14.3%

Valuation

PE Ratio -0.02

Forward PE 5.95

PEG Ratio -0.00

Forward PEG 0.00

PS Ratio 0.01

Forward PS 0.00

PB Ratio -0.00

P/FCF Ratio N/A

P/Adj. FCF Ratio N/A

P/OCF Ratio N/A

EV/Sales 6.21

EV/EBIT -8.25

EV/EBITDA -13.86

EV/FCF N/A

Earnings Yield -4435.0%

FCF Yield 0.0%

Adj. FCF Yield 0.0%

Financial Health

Net Debt ¥3.17B

Total Debt ¥3.63B

Cash & Short-Term Investments ¥297.79M

Total Assets ¥6.55B

Current Ratio 0.48

Quick Ratio 0.46

Debt / Equity Ratio -1.73

Debt / EBITDA -15.08

Debt / FCF N/A

OCF / Debt 0.00

Interest Coverage -1.57

Altman Z-Score -1.26

Piotroski F-Score 7

Margins & Profitability

Gross Profit Margin 6.9%

Operating Profit Margin -75.2%

EBITDA Margin -20.7%

Net Profit Margin -21.3%

FCF Margin 0.0%

Adj. FCF Margin 0.0%

SBC / Revenue 0.0%

SBC Impact (per share) N/A

Returns

Return on Assets -1.9%

Return on Equity 5.7%

Return on Invested Capital -4.3%

Return on Capital Employed -5.2%

Return on Tangible Assets -2.3%

Historical Growth (CAGR)

Revenue CAGR 3Y 5.8%

Revenue CAGR 5Y 21.6%

Revenue CAGR 10Y 2.9%

EPS CAGR 3Y 37.5%

EPS CAGR 5Y 38.4%

EPS CAGR 10Y 0.6%

FCF CAGR 3Y 9.9%

FCF CAGR 5Y 22.5%

FCF CAGR 10Y -2.1%

Analyst Forecasts

Analyst Rating Hold

Analyst Count 0

EPS Growth Next 3Y 32.9%

Revenue Growth Next 3Y -23.4%

Earnings Date Sep 24, 2026

EPS Estimate (next Q) N/A

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Cash Flow

Operating Cash Flow ¥0

Free Cash Flow ¥0

Adj. Free Cash Flow ¥0

FCF Per Share $0

OCF Per Share $0

OCF/S Ratio 0.0%

Income Statement

Revenue ¥538.29M

Gross Profit ¥6.48M

Operating Income ¥-404.79M

EBITDA ¥-241.05M

Net Income ¥-159.59M

EPS (Diluted) -$1,102.50

Revenue / Employee $882.43K

Profit / Employee $-261.62K

Employees 610